Biblio

Author Title [ Type

] Year

Filters: Author is Zhang, Xiao-Hui [Clear All Filters]

Journal Article

Tang, F.-F., Huang, X.-J., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, Y., Wang, J.-Z., et al. (2016). Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.Leuk Res47, 8-15.

Xu, L.-P., Xu, Z.-L., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, J.-Z., Wang, Y., et al. (2016). Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Biol Blood Marrow Transplant.

Han, X.-H., Wang, C.-L., Xie, Y., Ma, J., Zhang, X.-H., Hu, Q.-W., Lin, G., Liu, S., and Lu, J.-G. (2014). Anti-metastatic effect and mechanisms of Wenshen Zhuanggu formula in Human breast Cancer cells.J Ethnopharmacol.

Shi, M.-M., Kong, Y., Song, Y., Sun, Y.-Q., Wang, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., and Huang, X.-J. (2016). Atorvastatin enhances endothelial cell function in post transplant poor graft function.Blood.

Ma, R., Huang, X.-J., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Yan, C.-H., Han, W., Wang, F.-R., Chen, Y.-H., Chen, H., et al. (2019). Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.Biol Blood Marrow Transplant.

Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 19.Biol Blood Marrow Transplant.

Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (.Biol Blood Marrow Transplant.

Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.

Jin, Y.-H., Hua, Q.-F., Zheng, J.-J., Ma, X.-H., Chen, T.-X., Zhang, S., Chen, B., Dai, Q., and Zhang, X.-H. (2018). Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.Cell Physiol Biochem49, 271-281.

Song, Y., Zhao, H.-Y., Lyu, Z.-S., Cao, X.-N., Shi, M.-M., Wen, Q.-, Tang, F.-F., Wang, Y., Xu, L.-P., Zhang, X.-H., et al. (2018). Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.

Chang, Y.-J., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., Yan, C.-H., et al. (2018). Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial.Biol Blood Marrow Transplant.

Guo, Z.-P., Wang, T., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, X.-J., and Chang, Y.-J. (2016). Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor.Transfus Apher Sci.

Chen, Y., Huang, X.-J., Wang, Y., Liu, K.-Y., Chen, H., Chen, Y.-H., Zhang, X.-H., Wang, F.-R., Han, W., Wang, J.-Z., et al. (2015). Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.Transfusion.

Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.

Zhang, Y.-Y., Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., et al. (2019). FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.Bone Marrow Transplant.

Wen, Q., Kong, Y., Zhao, H.-Y., Zhang, Y.-Y., Han, T.-T., Wang, Y., Xu, L.-P., Zhang, X.-H., and Huang, X.-J. (2019). G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant.

Zhang, X.-H., Feng, F.-E., Han, W., Wang, F.-R., Wang, J.-Z., Wang, Y., Chen, Y., Fu, H.-X., Mo, X.-D., Zhang, Y.-Y., et al. (2016). High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation.Thromb Res144, 6-11.

Yan, C.-H., Wang, Y., Mo, X.-D., Sun, Y.-Q., Wang, F.-R., Fu, H.-X., Chen, Y., Han, T.-T., Kong, J., Cheng, Y.-F., et al. (2018). Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.Clin Infect Dis67, S162-S173.

Kong, Y., Song, Y., Hu, Y., Shi, M.-M., Wang, Y.-T., Wang, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., Deng, H.-K., et al. (2016). Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.Oncotarget.

Wang, Y.-T., Kong, Y., Song, Y., Han, W., Zhang, Y.-Y., Zhang, X.-H., Chang, Y.-J., Jiang, Z.-F., and Huang, X.-J. (2016). Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.

Lv, M., Zhao, X.-S., Hu, Y., Chang, Y.-J., Zhao, X.-Y., Kong, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., and Huang, X.-J. (2014). Monocytic and Promyelocytic Myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.Am J Hematol.

Huo, M.-R., Xu, Y.-J., Zhai, S.-Z., Lv, M., Wang, Y., Cao, L.-Q., Xu, L.-P., Zhang, X.-H., Chen, H., Chen, Y.-H., et al. (2018). Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.Hum Immunol.

Wang, X.-Y., Fan, Q.-Z., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., et al. (2019). The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.Cytometry B Clin Cytom.

Tian, D.-M., Wang, Y., Zhang, X.-H., Liu, K.-Y., Huang, X.-J., and Chang, Y.-J. (2016). Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.Plos One11, e0156777.

Zhang, X.-H., Wang, G.-X., Zhu, H.-H., Liu, Y.-R., Xu, L.-P., Han, W., Chen, H., Chen, Y.-H., Wang, F.-R., Wang, J.-Z., et al. (2015). Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Ann Hematol.

Pages